spot_img
Sunday, July 3, 2022
More
    HomeHealthEuropean Commission investigates Vifor for 'disparaging' rival drug

    European Commission investigates Vifor for ‘disparaging’ rival drug

    -



    The European Fee has opened an investigation into allegations that Vifor Pharma unfold deceptive details about a rival remedy to its blockbuster drug for iron deficiency, the most recent signal of governments cracking down on anticompetitive practices within the pharmaceutical business.

    In a press release, the EC defined that Vifor could have disparaged its “closet and, probably, solely” competitor to its Ferinject medication within the European market. Particularly, the worldwide drug firm ran a “deceptive communication marketing campaign,” primarily concentrating on well being care suppliers, a few remedy bought by Pharmacosmos, a small, household run firm based mostly in Denmark.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,380FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts